Netherlands — Bharat WorldMeds

India ships $396M in pharmaceutical products to Netherlands each year, making it the #6 export destination. Both countries track this trade: Eurostat import data confirms the scale.

Dual-source profile. Both series show HS Chapter 30 (finished pharmaceutical products) aligned to calendar year (Jan–Dec). Eurostat records what Netherlands imports from India. DGCIS records what India exports to Netherlands. Category and product detail from DGCIS.

$396M

Scale

Netherlands' healthcare system receives $396M in Indian pharmaceutical products each year — affordable, quality medicine.

66%

Medicine

Primarily medicines (66%), supplemented by medicine ingredients and surgical & hospital supplies.

3.3×

Trajectory

Rapid expansion: Netherlands' imports of Indian pharmaceutical products have grown 3.3× over the past decade, from $120M to $396M.

Context

A top-10 export destination, and a key pharmaceutical market in Europe.

✦

Impact

Indian pharmaceutical companies have both exported to and invested directly in Netherlands — building trade and operational presence.

Non-Chapter-30 pharma categories from DGCIS (487-code basket)

Medicines $497M (66.3%) Medicine Ingredients $210M (28.0%) Surgical & Hospital Supplies $25.6M (3.4%) Traditional & Herbal $11.6M (1.5%) Vaccines $5.1M (0.7%)

Active Pharmaceutical Ingredients DGCIS India-side

India also supplied $191M in active pharmaceutical ingredients and bulk drugs to Netherlands in 2025 (India-reported, DGCIS).

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Netherlands: $4.1B across 162 filings (2011-2025).